The introduction of halothane into clinical practice: The Oxford experience

被引:4
|
作者
O'Brien, H. D. [1 ]
机构
[1] Prince Wales Hosp, Dept Anaesthet, Sydney, NSW, Australia
关键词
anaesthesia; halothane; history; Oxford; Nuffield Department;
D O I
10.1177/0310057X0603401S03
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
This paper reviews the clinical situation in anaesthesia before the introduction of halothane into clinical practice in 1956, emphasising the limitations of agents available at the time. The background to the development of halogenated hydrocarbon compounds as anaesthesia agents is presented, including the involvement of Imperial Chemical Industries in England. The Nuffield Department of Anaesthetics was involved in the clinical trials and the designing and execution of these. The results of their work and the problems encountered are presented.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 50 条
  • [1] Introduction of array CGH into the clinical setting: The Oxford Laboratory experience
    Crocker, Mark
    Candlin, R.
    Connell, L.
    Knight, S. J. L.
    Regan, R.
    Smith, K.
    JOURNAL OF MEDICAL GENETICS, 2006, 43 : S94 - S94
  • [2] HALOTHANE IN CLINICAL-PRACTICE
    SMITH, G
    BRITISH JOURNAL OF ANAESTHESIA, 1981, 53 : S17 - S25
  • [3] Use of the Oxford Foot Model in clinical practice
    Jennifer McCahill
    Julie Stebbins
    Tim Theologis
    Journal of Foot and Ankle Research, 1 (Suppl 1)
  • [4] Experience of clinical risk management in obstetrics in Oxford
    Mant, J
    Dineen, M
    Couves, J
    Imhof, R
    BRITISH MEDICAL JOURNAL, 1998, 316 (7124): : 73 - 73
  • [5] Anemia in Clinical Practice: Introduction
    Cappellini, Maria-Domenica
    Beris, Photis
    SEMINARS IN HEMATOLOGY, 2015, 52 (04) : 259 - 260
  • [6] Introduction to Sertindole in Clinical Practice
    Joseph Peuskens
    CNS Drugs, 2004, 18 : 1 - 4
  • [7] Introduction of SGRT in clinical practice
    Beer, K. T.
    TECHNICAL INNOVATIONS & PATIENT SUPPORT IN RADIATION ONCOLOGY, 2022, 21 : 27 - 30
  • [8] Introduction to sertindole in clinical practice
    Peuskens, J
    CNS DRUGS, 2004, 18 (Suppl 2) : 1 - 4
  • [9] Oxford Miniature Vaporiser for halothane in ventilated asthmatics
    R Nagappan
    J Botha
    S Vij
    I Carney
    J Copland
    Critical Care, 10 (Suppl 1):
  • [10] EFFICACY OF OXFORD MINIATURE VAPORIZER (OMV) FOR HALOTHANE
    HALDEMANN, G
    HOSSLI, G
    SCHAER, H
    ANAESTHESIST, 1973, 22 (08): : 339 - 344